相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai)
Yiqi Du et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Family History of Gastric Cancer and Helicobacter pylori Treatment
Ii Ju Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial
Jie Pan et al.
FRONTIERS OF MEDICINE (2020)
Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics
Muhammad Miftahussurur et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single-center prospective pilot study
Yong Hwan Kwon et al.
HELICOBACTER (2019)
Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia
Tsogt-Ochir Byambajav et al.
FRONTIERS IN PHARMACOLOGY (2019)
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (vol 112, pg 212, 2017)
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
Marin M. Jukic et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study
D. -S. Liu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori
Neus Munoz et al.
HELICOBACTER (2018)
Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection
Wen Zhong Liu et al.
HELICOBACTER (2018)
Epidemiology of Helicobacter pylori infection
Olga Sjomina et al.
HELICOBACTER (2018)
Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel
Dorota Danielak et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2017)
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial
Ping-I Hsu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Review article: the global emergence of Helicobacter pylori antibiotic resistance
I. Thung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis
Beom Jin Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
Yue-Xi Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
Guang-Hong Jheng et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study
Jyh-Ming Liou et al.
PLOS ONE (2015)
CYP2C19 polymorphism influences Helicobacter pylori eradication
Chao-Hung Kuo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Prevalence of Primary and Secondary Antimicrobial Resistance of Helicobacter pylori in Korea from 2003 through 2012
Jung Won Lee et al.
HELICOBACTER (2013)
Levofloxacin-containing Triple and Sequential Therapy or Standard Sequential Therapy as the First Line Treatment for Helicobacter pylori Eradication in China
Juan Qian et al.
HELICOBACTER (2012)
The Efficacy of Second-Line Anti-Helicobacter pylori Therapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study
Seng-Kee Chuah et al.
HELICOBACTER (2012)
Efficacy of 2-Week, Second-Line Helicobacter pylori Eradication Therapy Using Rabeprazole, Amoxicillin, and Metronidazole for the Japanese Population
Kazutoshi Hori et al.
HELICOBACTER (2011)
Impact of Quadruple Regimen of Clarithromycin Added to Metronidazole-Containing Triple Therapy Against Helicobacter pylori Infection Following Clarithromycin-Containing Triple-Therapy Failure
Nobue Ueki et al.
HELICOBACTER (2009)
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
Chao-Hung Kuo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies
SD Georgopoulos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori
MS Osato et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen
R Sotoudehmanesh et al.
DIGESTION (2001)
分享论文
